A Critical Role for the TLR4/TRIF Pathway in Allogeneic Hematopoietic Cell Rejection by Innate Immune Cells Running title: Role of TLR4/TRIF Pathway in Bone Marrow Cell Rejection

Abstract We show for the first time that signaling through the TLR4/TRIF pathway plays a critical role in allogeneic bone marrow cell (BMC) rejection. This appears to be unique to BMC as organ allografts are rejected mainly via MyD88 signaling. Using T or T/B cell-deficient mice, we found that BMC allorejection occurred early before T cell activation and was T and B cell-independent, suggesting an effector role for innate immune cells in BMC rejection. We further demonstrated the innate immune signaling in BMC allorejection by showing superior engraftment in mice deficient in TRIF or TLR4 but not MyD88 or TLR3. The restored cytotoxicity in TRIF deficient recipients transferred with wildtype F4/80 + or NK1.1 + cells suggests TRIF signaling dependence on macrophages or NK cells in early BMC rejection. Production of the proinflammatory cytokine IL-6 and TRIF relevant chemokine MCP-1 was significantly increased early after bone marrow transplantation. In vivo specific depletion of macrophages or NK innate immune cells in combination with anti-CD154/rapamycin resulted in additive-enhanced allogeneic engraftment. The requirement for irradiation was completely eliminated when both macrophages and NK cells were depleted in combination with anti-CD154/rapamycin to target T and B cells, supporting the hypothesis that two barriers involving innate and adaptive immunity exist in mediating rejection of allogeneic BMC. In summary, our results clearly demonstrate a previously unappreciated role for innate immunity in BMC allorejection via signaling through a unique MyD88-independent TLR4/TRIF mechanism. These findings may have direct clinical impact on strategies for conditioning recipients for stem cell transplantation.

[1]  S. Ildstad,et al.  Innate and Adaptive Immune Responses Are Tolerized in Chimeras Prepared With Nonmyeloablative Conditioning , 2012, Transplantation.

[2]  Himanshu Kumar,et al.  Toll-like receptors and innate immunity. , 2009, Biochemical and biophysical research communications.

[3]  M. Yamazaki,et al.  TLR Agonists Prevent the Establishment of Allogeneic Hematopoietic Chimerism in Mice Treated with Costimulation Blockade12 , 2009, The Journal of Immunology.

[4]  P. Chilton,et al.  Strategic Nonmyeloablative Conditioning: CD154:CD40 Costimulatory Blockade at Primary Bone Marrow Transplantation Promotes Engraftment for Secondary Bone Marrow Transplantation after Engraftment Failure1 , 2008, The Journal of Immunology.

[5]  A. Tambur,et al.  Yin and yang of cytokine regulation in solid organ graft rejection and tolerance. , 2008, Clinics in laboratory medicine.

[6]  R. Lechler,et al.  Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1–dependent leukocyte recruitment in vivo , 2008, The Journal of experimental medicine.

[7]  A. Chong,et al.  Toll-like receptor signaling in transplantation. , 2008, Current opinion in organ transplantation.

[8]  S. Dower,et al.  The role of TLR activation in inflammation , 2008, The Journal of pathology.

[9]  M. Rosengart,et al.  HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.

[10]  K. Wood,et al.  Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? , 2007, Transplantation.

[11]  D. Greiner,et al.  Type 1 IFN Mediates Cross-Talk between Innate and Adaptive Immunity That Abrogates Transplantation Tolerance12 , 2007, The Journal of Immunology.

[12]  P. Noble,et al.  Hyaluronan in tissue injury and repair. , 2007, Annual review of cell and developmental biology.

[13]  M. Rigby,et al.  NK Cells Rapidly Reject Allogeneic Bone Marrow in the Spleen Through a Perforin‐ and Ly49D‐Dependent, but NKG2D‐Independent Mechanism , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  D. Goldstein,et al.  The Identity of Innate Immune Activators in Organ Transplantation: Origins from Within or Exterior to the Host? , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  L. Turka,et al.  The Innate Immune System in Allograft Rejection and Tolerance1 , 2007, The Journal of Immunology.

[16]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[17]  P. Chilton,et al.  Addition of Cyclophosphamide to T-cell Depletion–Based Nonmyeloablative Conditioning Allows Donor T-cell Engraftment and Clonal Deletion of Alloreactive Host T-cells After Bone Marrow Transplantation , 2007, Transplantation.

[18]  D. Goldstein.  Toll like receptors and acute allograft rejection. , 2006, Transplant immunology.

[19]  Jason A. Skinner,et al.  Bordetella bronchiseptica Modulates Macrophage Phenotype Leading to the Inhibition of CD4+ T Cell Proliferation and the Initiation of a Th17 Immune Response1 , 2006, The Journal of Immunology.

[20]  P. Chilton,et al.  Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. , 2006, Blood.

[21]  B. Tesar,et al.  Absence of Innate MyD88 Signaling Promotes Inducible Allograft Acceptance1 , 2006, The Journal of Immunology.

[22]  S. Akira,et al.  TLR Engagement Prevents Transplantation Tolerance , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  T. Fujisawa,et al.  Anti‐Type V Collagen Lymphocytes that Express IL‐17 and IL‐23 Induce Rejection Pathology in Fresh and Well‐Healed Lung Transplants , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  D. Goldstein,et al.  The role of toll-like receptors in solid organ transplantation. , 2006, Transplantation.

[25]  C. Larsen,et al.  NK Cells Mediate Costimulation Blockade‐Resistant Rejection of Allogeneic Stem Cells During Nonmyeloablative Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  P. Chilton,et al.  NK Cells Play a Critical Role in the Regulation of Class I-Deficient Hemopoietic Stem Cell Engraftment: Evidence for NK Tolerance Correlates with Receptor Editing1 , 2005, The Journal of Immunology.

[27]  R. Pawlick,et al.  Robust Tolerance to Fully Allogeneic Islet Transplants Achieved by Chimerism with Minimal Conditioning , 2005, Transplantation.

[28]  S. Keshavjee,et al.  Innate Immunity and Organ Transplantation: The Potential Role of Toll‐like Receptors , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[30]  P. Chilton,et al.  Production of Donor T Cells Is Critical for Induction of Donor-Specific Tolerance and Maintenance of Chimerism1 , 2004, The Journal of Immunology.

[31]  D. Schwartz,et al.  The role of innate immunity in acute allograft rejection after lung transplantation. , 2003, American journal of respiratory and critical care medicine.

[32]  Jiahuai Han,et al.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.

[33]  S. Akira,et al.  Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.

[34]  S. Akira,et al.  Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. , 2003, The Journal of clinical investigation.

[35]  R. Noelle,et al.  Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. , 2002, Blood.

[36]  Govinda Rao,et al.  IRF3 mediates a TLR3/TLR4-specific antiviral gene program. , 2002, Immunity.

[37]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[38]  A. Luster.  The role of chemokines in linking innate and adaptive immunity. , 2002, Current opinion in immunology.

[39]  T. Ahrens,et al.  Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4 , 2002, The Journal of experimental medicine.

[40]  A. Gurney,et al.  IL‐17: prototype member of an emerging cytokine family , 2002, Journal of leukocyte biology.

[41]  S. Akira,et al.  Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.

[42]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[43]  M. Maris,et al.  Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century. , 2001, Frontiers in bioscience : a journal and virtual library.

[44]  M. Maris,et al.  Non-myeloablative hematopoietic stem cell transplantation. , 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[45]  A. Mellor,et al.  Differential Susceptibility of Heart, Skin, and Islet Allografts to T Cell-Mediated Rejection1 , 2001, The Journal of Immunology.

[46]  W. Hancock,et al.  Ischemia-reperfusion injury. , 2001, Transplantation proceedings.

[47]  M. Wilhelm,et al.  Accelerated graft dysfunction in renal isografts from non-heart-beating donors. , 2001, Transplantation proceedings.

[48]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[49]  M. Sykes,et al.  Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment , 2000, Nature Medicine.

[50]  H. Kolb,et al.  Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1 , 2000, The Journal of Immunology.

[51]  T. K. van den Berg,et al.  Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. , 1996, Journal of immunological methods.

[52]  W. Fanslow,et al.  Human IL-17: a novel cytokine derived from T cells. , 1995, Journal of immunology.

[53]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[54]  M. Bennett,et al.  PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTS , 1971, The Journal of experimental medicine.

[55]  D. Kreisel,et al.  Monocyte differentiation is controlled by MyD88 after mouse orthotopic lung transplantation. , 2009, Transplantation proceedings.